Literature DB >> 19912303

Depression and quality of life during treatment of ocular bulb removal in individuals with uveal melanoma.

T A C Amaro1, L Yazigi, C Erwenne.   

Abstract

The objective of this study is to asses the emotional repercussions in individuals with uveal melanoma referred for surgery, during the diagnosis and preoperative, post-surgery and late post-surgery phases. The clinical qualitative assessment used the Beck Depression Inventory and the Medical Outcomes Study 36-Item Short-Form Health Survey. Twenty patients were individually assessed, 13 men and 7 women, with an average age of 52. Before surgery, patients appeared fragile and impacted by the diagnosis and treatment, showing a minimum to mild state of depression and a quality of life affected by emotional and physical concepts. Three months after surgery, the patients showed a mild to severe state of depression. This depression had an effect on the physical, vitality, emotional, mental health and social life concepts, the emotional concept being the most affected. One year after the surgery, patients presented a minimum state of depression and quality of life had most health concepts in balance. It was concluded that the worst moment for the patient is 3 months after the surgery, when they appear more fragile with difficulties of adaptation, anxiety and depression. One year after the surgery, they appear more structured and with a more balanced quality of life.

Entities:  

Mesh:

Year:  2009        PMID: 19912303     DOI: 10.1111/j.1365-2354.2009.01073.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  10 in total

1.  The Prevalence of Depression and Depressive Symptoms among Eye Disease Patients: A Systematic Review and Meta-analysis.

Authors:  Yajing Zheng; Xiaohang Wu; Xiaoming Lin; Haotian Lin
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

2.  Analysis on the psychological characteristics of patients with acute iridocyclitis.

Authors:  Wei Sun; Fan Wu; Jun Kong; Yukiko Nakahara; Xiao-Yan Li
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

3.  Two-year patient-reported outcomes following treatment of uveal melanoma.

Authors:  L Hope-Stone; S L Brown; H Heimann; B Damato; P Salmon
Journal:  Eye (Lond)       Date:  2016-09-02       Impact factor: 3.775

4.  Health-related quality of life after surgical removal of an eye.

Authors:  Takaaki Kondo; Walter T Tillman; Terry L Schwartz; John V Linberg; J Vernon Odom
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2013 Jan-Feb       Impact factor: 1.746

5.  Impact of Adjuvant Ocular Interventions on the Quality of Life of Patients with Uveal Melanoma after Proton Beam Therapy.

Authors:  Johannes Gollrad; Christopher Rabsahl; Antonia M Joussen; Andrea Stroux; Volker Budach; Dirk Böhmer; Alexander Böker
Journal:  Ocul Oncol Pathol       Date:  2021-11-08

6.  Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.

Authors:  A Klingenstein; C Fürweger; A K Mühlhofer; S F Leicht; U C Schaller; A Muacevic; B Wowra; C Hintschich; K H Eibl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-16       Impact factor: 3.117

7.  Patient-Reported Outcomes and Quality of Life after Treatment for Choroidal Melanoma.

Authors:  Bertil Damato; Laura Hope-Stone; Bruce Cooper; Steve Brown; Heinrich Heimann; Laura Dunn
Journal:  Ocul Oncol Pathol       Date:  2019-03-25

Review 8.  Quality of Life, Depression, and Anxiety in Patients with Uveal Melanoma: A Review.

Authors:  Mario Miniati; Maria Grazia Fabrini; Federica Genovesi Ebert; Maricia Mancino; Alessandra Maglio; Gabriele Massimetti; Enrico Massimetti; Donatella Marazziti
Journal:  J Oncol       Date:  2018-03-20       Impact factor: 4.375

9.  Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study.

Authors:  Marietta Lieb; Sefik Tagay; Anja Breidenstein; Tobias Hepp; Claudia H D Le Guin; Jennifer Scheel; Dietmar R Lohmann; Norbert Bornfeld; Martin Teufel; Yesim Erim
Journal:  BMC Psychol       Date:  2020-01-31

10.  A Novel Stimuli-Responsive Injectable Antibacterial Hydrogel to Achieve Synergetic Photothermal/Gene-Targeted Therapy towards Uveal Melanoma.

Authors:  Shaoyun Wang; Baohui Chen; Liping Ouyang; Donghui Wang; Ji Tan; Yuqin Qiao; Shengfang Ge; Jing Ruan; Ai Zhuang; Xuanyong Liu; Renbing Jia
Journal:  Adv Sci (Weinh)       Date:  2021-07-31       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.